The global kinase inhibitors market reached $28.1 billion in 2010 and
nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by
2016, a compound annual growth rate (CAGR) of 6.7%.
The emerging markets segment for kinase inhibitors reached $2.9 billion in
2010 and $4.1 billion in 2011. The market is expected to reach $8.4 billion by
2016, a CAGR of 15.2%.
The emerging markets segment for antibody kinase inhibitors reached $1.8
billion in 2010 and $2.1 billion in 2011. The market is expected to reach $4.3
billion by 2016, a CAGR of 15.2%.
GLOBAL REVENUE OF KINASE INHIBITORS MARKET, 2009-2016
Source: BCC Research
BCC's goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for kinase inhibitors. The key
objective is to present a comprehensive analysis and the future direction of
kinase inhibitors to provide an important tool for the usage of these types of
This report explores present and future strategies within the kinase
inhibitors market, which includes tyrosine inhibitors, multi-target kinase
inhibitors, serine/ threonine inhibitors and monoclonal antibody kinase
inhibitors. The direction of the market, its setbacks and the needs of the
market are discussed in this report. The classifications, comparisons and
usage of these types of enzyme inhibitors are also examined in the report.
A detailed analysis of the kinase inhibitors industry structure has been
conducted. Revenues are broken down by region. Sales figures are estimated for
the five-year period from 2011 through 2016.
Applications for kinase inhibitors are also discussed separately in the
report, with emphasis on the usage of the inhibitors in therapeutic categories
and various disease sectors. The report also covers significant patents and a
summary of patents awarded in each category.
SCOPE OF THE STUDY
The scope of this study encompasses kinase inhibitors in pharmaceutical and
biotechnology markets. BCC analyzes each market and its applications,
regulatory environment, technology, market projections and market share.
Technological issues include the latest trends and developments. The emerging
market for enzyme inhibitors includes India, China, Japan, South Korea,
Taiwan, Canada, Africa, Australia and New Zealand and others countries.
Both primary and secondary research methodologies were used in preparing this
study. BCC conducted a comprehensive literature search, which included
technical newsletters and journals and many other sources. Data were collected
through interviews and correspondence with manufacturers of enzyme inhibitors
and technical experts. Projections were based on estimates such as the current
number of end users, potential end users, mergers and acquisitions, and market
Many companies active in the kinase inhibitor industry were surveyed to obtain
data for this study. Included were manufacturers and end users of kinase
inhibitors in therapeutic categories and various disease sectors industries.
Data were gathered from various industry sources. BCC spoke with officials
within the industry, consulted newsletters, company literature, product
literature, and a host of technical articles, journals, indexes, and
abstracts. Exhaustive investigations of databases by key terminology were
conducted. In addition, data were compiled from current financial, trade and
ABOUT THE AUTHOR
A team of professionals in the biotechnology industry carried out this study.
The project manager is Shalini S. Dewan, who holds a master's degree in
pharmaceutical chemistry and has over 14 years of industry experience. Among
the research topics she has covered are studies on compounds of potential
pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was
awarded a Gold Medal by the Prime Minister of India for her work and has
worked with top companies in India and in the U.S.
Table of Contents
Table of Contents
Kinase Inhibitors: Global Markets -- Focus on Emerging Markets
Chapter - 1: INTRODUCTION - Complimentary
REASONS FOR DOING THIS STUDY
SCOPE OF THE STUDY
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
Chapter - 2: SUMMARY
Table Summary: GLOBAL REVENUE OF KINASE INHIBITORS MARKET, THROUGH 2016
Figure Summary: GLOBAL REVENUE OF KINASE INHIBITORS MARKET, 2009-2016
Chapter - 3: OVERVIEW
CLASSIFICATION BY TYPES OF AMINO ACID PHOSPHORYLATION
CLASSIFICATION BY SITE OF ACTION
Chapter - 4: REGULATORY ASPECTS
MARKET LEADERS AND THEIR PRODUCTS FOR KINASE INHIBITORS
Table 13: LEADING MANUFACTURERS AND SUPPLIERS OF RECEPTOR TYROSINE
Table 14: LEADING MANUFACTURERS AND SUPPLIERS OF NON-RECEPTOR TYROSINE
Table 15: LEADING MANUFACTURERS AND SUPPLIERS OF MULTI-TARGET TYROSINE
Table 16: LEADING MANUFACTURERS AND SUPPLIERS OF SERINE AND THREONINE
Table 17: LEADING MANUFACTURERS AND SUPPLIERS OF ANTIBODY KINASE
Chapter - 5: NEW DEVELOPMENTS
(RECEPTOR) TYROSINE KINASE INHIBITORS (TKIS)
(NON-RECEPTOR) TYROSINE KINASE INHIBITORS (TKIS)
SERINE/THREONINE KINASE INHIBITOR
OTHER KINASE INHIBITOR PRODUCTS UNDER DEVELOPMENT
Table 18: CLINICAL TRIALS IN EPIDERMAL GROWTH FACTOR RECEPTOR
Table 19: CLINICAL TRIALS IN HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2